India · Delayed Price · Currency is INR Dr. Reddy's Laboratories Statistics
Total Valuation
BOM:500124 has a market cap or net worth of INR 1.02 trillion. The enterprise value is 1.01 trillion.
| Market Cap | 1.02T |
| Enterprise Value | 1.01T |
Important Dates
The last earnings date was Friday, October 23, 2026.
| Earnings Date | Oct 23, 2026 |
| Ex-Dividend Date | Jul 10, 2026 |
Share Statistics
BOM:500124 has 832.98 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 832.98M |
| Shares Outstanding | 832.98M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 26.73% |
| Owned by Institutions (%) | 58.93% |
| Float | 599.97M |
Valuation Ratios
The trailing PE ratio is 36.46 and the forward PE ratio is 23.84. BOM:500124's PEG ratio is 6.07.
| PE Ratio | 36.46 |
| Forward PE | 23.84 |
| PS Ratio | 3.09 |
| PB Ratio | 2.62 |
| P/TBV Ratio | 3.79 |
| P/FCF Ratio | 73.69 |
| P/OCF Ratio | 33.00 |
| PEG Ratio | 6.07 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.64, with an EV/FCF ratio of 73.24.
| EV / Earnings | 36.23 |
| EV / Sales | 3.07 |
| EV / EBITDA | 19.64 |
| EV / EBIT | 33.57 |
| EV / FCF | 73.24 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.93 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.40 |
| Debt / FCF | 5.22 |
| Interest Coverage | 6.71 |
Financial Efficiency
Return on equity (ROE) is 7.34% and return on invested capital (ROIC) is 6.20%.
| Return on Equity (ROE) | 7.34% |
| Return on Assets (ROA) | 3.38% |
| Return on Invested Capital (ROIC) | 6.20% |
| Return on Capital Employed (ROCE) | 7.19% |
| Weighted Average Cost of Capital (WACC) | 5.58% |
| Revenue Per Employee | 11.98M |
| Profits Per Employee | 1.02M |
| Employee Count | 27,527 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.12 |
Taxes
In the past 12 months, BOM:500124 has paid 7.64 billion in taxes.
| Income Tax | 7.64B |
| Effective Tax Rate | 21.69% |
Stock Price Statistics
The stock price has decreased by -3.92% in the last 52 weeks. The beta is 0.25, so BOM:500124's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -3.92% |
| 50-Day Moving Average | 1,192.55 |
| 200-Day Moving Average | 1,243.17 |
| Relative Strength Index (RSI) | 53.80 |
| Average Volume (20 Days) | 110,373 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:500124 had revenue of INR 329.84 billion and earned 27.99 billion in profits. Earnings per share was 33.58.
| Revenue | 329.84B |
| Gross Profit | 163.24B |
| Operating Income | 30.20B |
| Pretax Income | 35.22B |
| Net Income | 27.99B |
| EBITDA | 49.93B |
| EBIT | 30.20B |
| Earnings Per Share (EPS) | 33.58 |
Balance Sheet
The company has 76.24 billion in cash and 72.29 billion in debt, with a net cash position of 3.96 billion or 4.75 per share.
| Cash & Cash Equivalents | 76.24B |
| Total Debt | 72.29B |
| Net Cash | 3.96B |
| Net Cash Per Share | 4.75 |
| Equity (Book Value) | 389.37B |
| Book Value Per Share | 463.83 |
| Working Capital | 143.08B |
Cash Flow
In the last 12 months, operating cash flow was 30.91 billion and capital expenditures -17.07 billion, giving a free cash flow of 13.84 billion.
| Operating Cash Flow | 30.91B |
| Capital Expenditures | -17.07B |
| Depreciation & Amortization | 19.73B |
| Net Borrowing | 11.32B |
| Free Cash Flow | 13.84B |
| FCF Per Share | 16.62 |
Margins
Gross margin is 49.49%, with operating and profit margins of 9.16% and 8.48%.
| Gross Margin | 49.49% |
| Operating Margin | 9.16% |
| Pretax Margin | 10.68% |
| Profit Margin | 8.48% |
| EBITDA Margin | 15.14% |
| EBIT Margin | 9.16% |
| FCF Margin | 4.20% |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.65%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 0.65% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 23.81% |
| FCF Payout Ratio | 31.27% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.65% |
| Earnings Yield | 2.74% |
| FCF Yield | 1.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:500124 is 1,283.65, which is 4.83% higher than the current price. The consensus rating is "Hold".
| Price Target | 1,283.65 |
| Price Target Difference | 4.83% |
| Analyst Consensus | Hold |
| Analyst Count | 37 |
| Revenue Growth Forecast (3Y) | 8.74% |
| EPS Growth Forecast (3Y) | 7.79% |
Stock Splits
The last stock split was on October 28, 2024. It was a forward split with a ratio of 5.
| Last Split Date | Oct 28, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |